-
By Staff Writer |
December 1, 2005
If you were to suggest to colleagues or clients that the biotechnology sector presents a good opportunity for investment, they might very well respond with...
-
By James J. Green, AdvisorOne |
December 1, 2005
Within the next 10 or 15 years there will be a big leap in human longevity that will radically change our society, will greatly affect...
-
By Staff Writer |
June 27, 2005
Going Off the Straight and Narrow
-
By Staff Writer |
August 18, 2004
Frank Sands Jr., manager since July 2000 S&P Rank: 3 Stars Bulking Up On Biotech
-
By Staff Writer |
March 24, 2004
S&P Rank: 3 Stars March 11, 2004 Biotechs High on Drug Approvals
-
By Staff Writer |
November 4, 2003
WESTMINSTER, Colo. (HedgeWorld.com)--Durus Life Sciences Master Fund Ltd. and its manager Durus Capital Management, Norwalk, Conn., settled claims with a biotechnology company it had invested...
-
By Staff Writer |
August 25, 2003
S&P Rank: 4 Stars Aug. 14, 2003 On the Cusp of a New Drug Boom Quick Take: Drug and biotech stocks suffered in 2002, hurt by poor earnings,...
-
By Staff Writer |
July 10, 2003
S&P Rank: 4 StarsJuly 2, 2003Balanced, with a
-
By Staff Writer |
April 7, 2003
April 3, 2003 -- Three Janus Capital Management analysts have been promoted to portfolio manager and will help oversee three of its stock mutual funds,...
-
By Staff Writer |
March 27, 2003
Good Prognosis for Medical Devices S&P Rank: